Objectives: We examined the safety and efficacy of nonculprit multivessel compared with
culprit-only stenting in patients with multivessel disease presenting with unstable angina or …

Objective: To investigate the major cardiac events at 1‐year follow‐up of multivessel versus
culprit‐vessel stenting in patients presenting with non‐ST elevation acute coronary …

Background: There is paucity of data concerning the optimal revascularization in patients
with mul-tivessel coronary artery disease (CAD) presenting non-ST-segment elevation acute …

Background: We sought to compare long‐term outcomes for multivessel revascularization
(MVR) vs single‐vessel revascularization (SVR) with drug‐eluting stents (DES) in patients …

BACKGROUND: Multivessel (MV) coronary artery disease (CAD) frequently exists in
patients presenting with non–ST-elevation (NSTE) acute coronary syndromes (ACSs) …

BACKGROUND: In patients with non-ST-elevation myocardial infarction (NSTEMI), current
guidelines did not recommend optimal revascularization management in multivessel …

Aims: To determine whether multivessel (MV) percutaneous coronary intervention (PCI)
performed in one procedure improves outcomes when compared to single-vessel (SV) PCI …

Objectives To evaluate in-hospital and long-term clinical outcomes in a large consecutive
series of patients undergoing percutaneous multivessel stent intervention. Background High …

Background: A large proportion of patients presenting with non–ST-segment elevation
myocardial infarction (NSTEMI) present with multivessel disease (MVD). There is uncertainty …

We evaluated the current short-and medium-term outcomes of complete revascularization,
compared to culprit lesion percutaneous coronary intervention (PCI), in patients with …